← SynDRA
AZD8329
SynDRA canonical compound SYN1964017 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | HSD11B1 |
|---|
| Mechanism of action | 11-beta hydroxysteroid dehydrogenase inhibitor |
|---|
| Indication | obesity |
|---|
| Disease area | endocrinology |
|---|
All known targets
Mechanisms of action (all sources)
- 11-beta hydroxysteroid dehydrogenase inhibitor
- HSD11B1 INHIBITOR
Cross-references
Synonyms
- AZD 8329
- UNII-5B38CV1212
- CHEMBL2177609
- 5B38CV1212
- 4-[4-(2-Adamantylcarbamoyl)-5-Tert-Butyl-Pyrazol-1-Yl]benzoic Acid
- XWBXJBSVYVJAMZ-UHFFFAOYSA-N
- SCHEMBL617351
- GTPL7715
- BDBM50399335
- 4-(4-(Adamant-2-ylcarbamoyl)-5-tert-butylpyrazol-1-yl)benzoic acid
- Benzoic acid, 4-(5-(1,1-dimethylethyl)-4-((tricyclo(3.3.1.13,7)dec-2-ylamino)carbonyl)-1H-pyrazol-1-yl)-
- 4-[4-(2-adamantylcarbamoyl)-5-tertbutyl-pyrazol-1-yl]benzoic acid
- 4-[4-(2-adamantylcarbamoyl)-5-tert-butylpyrazol-1-yl]benzoic ac
Look up AZD8329 in the interactive SynDRA portal →